Clinical Trials
2 trialsNCT00469859 2017-03-15
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Children's Oncology Group
Phase 1/2 Completed
NCT00668421 2014-11-26
CEP-701 (Lestaurtinib) in Myelofibrosis
Icahn School of Medicine at Mount Sinai
Phase 1/2 Unknown